Abstract
This study aims to analyze the clinical and immunologic features of SLE in Jordan, while also investigating the impact of age and gender on disease presentation. The study included 275 patients diagnosed with SLE. Data were collected through meticulous patient interviews and thorough examination of patient hospital records. The cohort exhibited a mean age of 36.8 ± 12.9 years, with an average disease duration of 7.0 ± 7.8 years. The mean age at diagnosis was 29.9 ± 12.1 years, and the female to male ratio was 7.8:1. The most frequently observed symptoms were arthralgia (90.2%), fatigue (80.7%), hematologic manifestations (62%), photosensitivity (60.7%), Raynaud's phenomenon (53.5%), and malar rash (50.9%). The frequencies of various autoantibodies were as follows: ANA (96.7%), anti-dsDNA (39.6%), anti-SSA/Ro (32.8%), anti-Sm (21.8%), anti-U1-RNP (20.6%), and anti-SSB/La (15.5%). Male patients tended to receive a diagnosis at a younger age and exhibited a higher likelihood of experiencing severe manifestations compared to females. Additionally, juvenile onset patients demonstrated an increased likelihood of fever, photosensitivity, myositis, and anti-dsDNA autoantibodies, while adult onset patients were more predisposed to having anti-Ro, anti-La, and RF autoantibodies. This study reveals that the most prevalent manifestations of SLE in the Jordanian cohort encompassed arthralgia, fatigue, and hematologic manifestations. The prevalence of alopecia and Raynaud's phenomenon exceeded that observed in other published cohorts, while arthritis and discoid rash were less frequently encountered. The study highlights that males are more susceptible to developing severe manifestations of SLE compared to females.
Similar content being viewed by others
Data availability
The data available with the author upon request.
References
Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9(5):A277–A287
Stojan G, Petri M (2018) Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 30(2):144–150
Fatoye F, Gebrye T, Mbada C (2022) Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis. Rheumatol Int 42(12):2097–2107
Alarcon G, McGwin G Jr, Petri M, Reveille J, Ramsey-Goldman R, Kimberly R et al (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11(2):95–101
Lau C, Yin G, Mok M (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15(11):715–719
Al Arfaj A, Khalil N (2009) Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia. Lupus 18(5):465–473
Al Dhanhani A, Agarwal M, Othman Y, Bakoush O (2017) Incidence and prevalence of systemic lupus erythematosus among the native Arab population in UAE. Lupus 26(6):664–669
Housey M, DeGuire P, Lyon-Callo S, Wang L, Marder W, McCune WJ et al (2015) Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program. Am J Public Health 105(5):e74–e79
Adwan M (2018) Clinical and serologic characteristics of systemic lupus erythematosus in the arab world: a pooled analysis of 3,273 patients. Arch Rheumatol 33(4):455
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis rheum 40(9):1725
Harley IT, Sawalha AH (2022) Systemic lupus erythematosus as a genetic disease. Clin Immunol 236:108953
Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS (2017) Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 13(8):799–814
Tan EM, Cohen AS, Fries JF, Masi AT, Mcshane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277
Feng J-B, Ni J-D, Yao X, Pan H-F, Li X-P, Xu J-H et al (2010) Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int 30:1017–1023
Garcia MA, Marcos J, Marcos A, Pons-Estel B, Wojdyla D, Arturi A et al (2005) Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus 14(12):938–946
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 72(2):113–124
Borba E, Araujo D, Bonfá E, Shinjo S (2013) Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations. Lupus 22(7):744–749
El Hadidi K, Medhat B, Abdel Baki N, Abdel Kafy H, Abdelrahaman W, Yousri A et al (2018) Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center. Lupus 27(6):1030–1038
Joo YB, Bae SC (2015) Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations. Int J Rheum 18(2):117–128
Khanfir MS, Houman MH, Cherif E, Hamzaoui A, Souissi S, Ghorbel IB et al (2013) TULUP (TU nisian LUP us): a multicentric study of systemic lupus erythematosus in Tunisia. Int J Rheum 16(5):539–546
Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A et al (2015) Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences. Medicine 94(1):e267
Nazarinia M, Ghaffarpasand F, Shamsdin A, Karimi A, Abbasi N, Amiri A (2008) Systemic lupus erythematosus in the Fars Province of Iran. Lupus 17(3):221–227
Lu L-J, Wallace DJ, Ishimori ML, Scofield R, Weisman MH (2010) Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus 19(2):119–129
Lao C, Van Dantzig P, White D, Rabindranath K, Foxall D, Lawrenson R (2023) Prevalence and outcomes of end-stage kidney disease in patients with systemic lupus erythematous: a population-based study. Rheumatol Int 44(3):469–475
Stefanidou S, Benos A, Galanopoulou V, Chatziyannis I, Kanakoudi F, Aslanidis S et al (2011) Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male: female comparison. Lupus 20(10):1090–1094
Mok C, Lau C, Chan T, Wong RW (1999) Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 8(3):188–196
Livingston B, Bonner A, Pope J (2011) Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus 20(13):1345–1355
Sharma H, Kaul A, Mohakuda SS, Behera MR, Bhadauria D, Agrawal V et al (2023) Clinicopathologic characteristics and outcomes of late onset lupus nephritis: a single centre experience. Rheumatol Int 43(10):1849–1858
Funding
No specific funding was received from public, commercial or not-for-profit bodies to carry out the work described in this article.
Author information
Authors and Affiliations
Contributions
All co-authors collectively bear full responsibility for the integrity and accuracy of every aspect of the work. MHA: Conceived and oversaw the study, formulated the initial manuscript, and critically reviewed and completed the final version. S YA, MI, RH, UQ, NA, MAJ and AAH: Contributed to data collection and drafting of the initial manuscript. FA: Manuscript writing and editing and evaluating research integrity.
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the Jordan University Hospital Institutional Review Board (protocol number 10/2024/6174), and all the procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the World Medical Association Declaration of Helsinki principles for this type of study.
Congress abstract publication
This work has not been presented at any congress either in abstract or full form.
Informed consent
Informed consent was obtained from patients who participated in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Adwan, M.H., Qasem, U., Atawnah, S.Y. et al. Insights into systemic lupus erythematosus: a retrospective observational study of clinical features, autoantibodies, and gender-related differences. Rheumatol Int (2024). https://doi.org/10.1007/s00296-024-05592-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00296-024-05592-7